162 related articles for article (PubMed ID: 26423033)
21. A Comparison of Protein Stability in Prefillable Syringes Made of Glass and Plastic.
Waxman L; Vilivalam VD
PDA J Pharm Sci Technol; 2017; 71(6):462-477. PubMed ID: 28819049
[TBL] [Abstract][Full Text] [Related]
22. High particle variability across siliconized and oil-free syringes and needles from the same lots.
do Monte Agra LL; da Cruz NFS; Linkuviene V; Carpenter JF; Farah ME; Melo GB; Maia M
Sci Rep; 2021 Feb; 11(1):4645. PubMed ID: 33633285
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Syringe Age Prior to Filling on Migration of Subvisible Silicone-Oil Particles into Drug Product.
Song J; Hu G; Hamzaoui H; Krishnamachari Y; Persak SC; Xi H; Su Y
J Pharm Sci; 2022 Dec; 111(12):3191-3194. PubMed ID: 36404459
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Protein Aggregates, Silicone Oil Droplets, and Protein-Silicone Interactions Using Imaging Flow Cytometry.
Probst C
J Pharm Sci; 2020 Jan; 109(1):364-374. PubMed ID: 31136765
[TBL] [Abstract][Full Text] [Related]
25. Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins.
Krayukhina E; Tsumoto K; Uchiyama S; Fukui K
J Pharm Sci; 2015 Feb; 104(2):527-35. PubMed ID: 25256796
[TBL] [Abstract][Full Text] [Related]
26. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
[TBL] [Abstract][Full Text] [Related]
27. Silicone oil induced aggregation of proteins.
Jones LS; Kaufmann A; Middaugh CR
J Pharm Sci; 2005 Apr; 94(4):918-27. PubMed ID: 15736189
[TBL] [Abstract][Full Text] [Related]
28. The risks behind the widespread use of siliconized syringes in the healthcare practice.
Melo GB; Shoenfeld Y; Rodrigues EB
Int J Retina Vitreous; 2021 Oct; 7(1):66. PubMed ID: 34717776
[TBL] [Abstract][Full Text] [Related]
29. An Assessment of the Ability of Submicron- and Micron-Size Silicone Oil Droplets in Dropped Prefillable Syringes to Invoke Early- and Late-Stage Immune Responses.
Krayukhina E; Yokoyama M; Hayashihara KK; Maruno T; Noda M; Watanabe H; Uchihashi T; Uchiyama S
J Pharm Sci; 2019 Jul; 108(7):2278-2287. PubMed ID: 30790580
[TBL] [Abstract][Full Text] [Related]
30. Quantitative assessment of silicone oil release with siliconized and silicone oil-free syringes by microflow imaging microscopy.
Agra LLDM; Cruz NFSD; Linkuviene V; Carpenter JF; Farah ME; Melo GB; Maia M
Arq Bras Oftalmol; 2022 Jul; ():. PubMed ID: 35857984
[TBL] [Abstract][Full Text] [Related]
31. Low molecular weight silicones particularly facilitate human serum albumin denaturation.
Nayef LM; Khan MF; Brook MA
Colloids Surf B Biointerfaces; 2015 Apr; 128():586-593. PubMed ID: 25800359
[TBL] [Abstract][Full Text] [Related]
32. PARTICULATE MATTER FROM SYRINGES USED FOR INTRAVITREAL INJECTIONS.
Dounce SM; Laskina O; Goldberg RA
Retina; 2021 Apr; 41(4):827-833. PubMed ID: 32956210
[TBL] [Abstract][Full Text] [Related]
33. Method to Determine Syringe Silicone Oil Layer Heterogeneity and Investigation of its Impact on Product Particle Counts.
Cua M; Martin D; Meza P; Torraca G; Pearson T; Cao S; Yang C
J Pharm Sci; 2020 Nov; 109(11):3292-3299. PubMed ID: 32679217
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Polymeric Syringes Used for Intravitreal Injection.
Peláez SS; Mahler HC; Koulov A; Joerg S; Matter A; Vogt M; Chalus P; Zaeh M; Sediq AS; Jere D; Mathaes R
J Pharm Sci; 2020 Sep; 109(9):2812-2818. PubMed ID: 32534032
[TBL] [Abstract][Full Text] [Related]
35. Do not flick or drop off-label use plastic syringes in handling therapeutic proteins before administration.
Kim NA; Kim DJ; Jeong SH
Int J Pharm; 2020 Sep; 587():119704. PubMed ID: 32739384
[TBL] [Abstract][Full Text] [Related]
36. Sweeping of Adsorbed Therapeutic Protein on Prefillable Syringes Promotes Micron Aggregate Generation.
Maruno T; Watanabe H; Yoneda S; Uchihashi T; Adachi S; Arai K; Sawaguchi T; Uchiyama S
J Pharm Sci; 2018 Jun; 107(6):1521-1529. PubMed ID: 29421215
[TBL] [Abstract][Full Text] [Related]
37. Variables Impacting Silicone Oil Migration and Biologics in Prefilled Syringes.
Gentile K; Huang C; Liu X; Whitty-Léveillé L; Hamzaoui H; Cristofolli E; Rayfield W; Afanador NL; Mittal S; Krishnamachari Y; Xi H; Zhao X
J Pharm Sci; 2023 Aug; 112(8):2203-2211. PubMed ID: 37244516
[TBL] [Abstract][Full Text] [Related]
38. Introducing the Alba
Chillon A; Pace A; Zuccato D
PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
[TBL] [Abstract][Full Text] [Related]
39. Effects of Product Handling Parameters on Particle Levels in a Commercial Factor VIII Product: Impacts and Mitigation.
Ueda T; Nakamura K; Abe Y; Carpenter JF
J Pharm Sci; 2019 Jan; 108(1):775-786. PubMed ID: 30196040
[TBL] [Abstract][Full Text] [Related]
40. Colloidal Instability Fosters Agglomeration of Subvisible Particles Created by Rupture of Gels of a Monoclonal Antibody Formed at Silicone Oil-Water Interfaces.
Mehta SB; Carpenter JF; Randolph TW
J Pharm Sci; 2016 Aug; 105(8):2338-48. PubMed ID: 27422087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
